• 제목/요약/키워드: recombinant human growth hormone (rHGH)

검색결과 4건 처리시간 0.02초

유전자 재조합 Human Growth Hormone의 성장촉진 효과에 관한 연구 (Growth Effects of Recombinant Human Growth Hormone)

  • 정요찬;송동호;조명행;구본흔;정광회;김경연;정경환;이은경;박두홍
    • Biomolecules & Therapeutics
    • /
    • 제3권3호
    • /
    • pp.233-237
    • /
    • 1995
  • The growth effects of newly developed recombinant human growth hormone (rHGH), were compared with those of Biotropine. For the effective evaluation, we examined the increasing rate of body weight and the thickness of tibial epiphysis as criteria of growth effects on hypophysectomised female rats treated with varing concentration of rHGH for 4 days. rHGH treated groups showed significant body weight gain which was less evident in Biotropine and vehicle treatment group. In tibial epiphyseal test, rHGH also showed clear effects compared to Biotropine and vehicle treatment group. Above findings indicate that newly developed rHGH has better effects of growth stimulation on female rats than Biotropine does.

  • PDF

Human growth hormone의 개발과 이에 따른 효능 및 안전성 평가 (Development of Recombinant Human Growth Hormone in Yeast: Efficacy Evaluation and Safety Assessment)

  • 이상균
    • 한국독성학회:학술대회논문집
    • /
    • 한국독성학회 1997년도 국제심포지움 및 추계학술대회
    • /
    • pp.38-42
    • /
    • 1997
  • 인간성장 호르몬은 191개의 아미노산으로 구성된 펩타이드 호르몬의 일종으로 사람의 뇌하수체에서 분비된다. 본연구의 목적은 저렴한 가격의 재조합 성장호르몬을 안정적으로 공급함은 물론 부작용을 최대한으로 줄이는데 있다. 효모에서의 성장호르몬 재조합 과정은 유전자조작과 이에따른 정제기술의 확립을 시작으로 물리 화학적 또는 생물학적 물성 연구, 다양한 전임상 시험 및 임상 시험의 단계를 수행한 후, 인허가 과정을 거쳐서 완료되었다. 다양한 실험 결과에 의하면 당소에서 재조합 기술로 생산한 고순도의 인간성장 호르몬은 안정된 물성을 보유하고 있을 뿐만아니라 전임상 시험 결과 인체 투여용량의 수십배의 고용량을 투여하여도 별다른 독성 증상을 관찰할 수 없었으며, 임상 시험에서도 대상 환아의 신장이 지속적으로 성장하는 등 만족할 만한 결과를 보여 주었다.

  • PDF

Effects of Three Dietary Growth Hormones on Growth Performance and Lysozyme Activity in Juvenile Olive Flounder, Paralichthys olivaceus

  • Lee, Seung-Hyung;Yoo, Gwang-Yeol;Park, Gun-Jun;Kim, Young-Chul;Lee, Jun-Ho;Bai, Sung-Chul C.
    • Fisheries and Aquatic Sciences
    • /
    • 제11권4호
    • /
    • pp.183-189
    • /
    • 2008
  • In this study, tests were conducted to investigate the effects of three dietary growth hormones, administered in various amounts, on the growth performance and lysozyme activity in juvenile olive flounder, Paralichthys olivaceus. Three dietary growth hormones, recombinant human growth hormone (rHGH), recombinant bovine somatotropin A (rBST A) and recombinant bovine somatotropin B (rBST B) were tested at three different supplemental levels (10, 20 or 40 mg/kg body weight per week) by a $3{\times}3$ factorial design and a complete randomized design in comparison to a control group. Fish were fed one of the ten experimental diets (control, $rHGH_{10}$, $rHGH_{20}$, $rHGH_{40}$, rBST $A_{10}$, rBST $A_{20}$, rBST $A_{40}$, rBST $B_{10}$, rBST $B_{20}$ and rBST $B_{40}$) for 6 weeks and afterward were analyzed for growth performance by measuring weight gain (WG), feed efficiency (FE), specific growth rate (SGR) and protein efficiency ratio (PER). Based on the factorial design analysis, fish fed rHGH diets demonstrated significantly higher growth performance than fish fed rBST A or rBST B diets. However there were no significant differences in WG, FE, SGR and PER between fish fed rBST A and rBST B diets. Neither hormone level nor the interaction between the different hormones and their various levels had a significant effect on WG, FE, SGR, PER, lysozyme activity or whole-body proximate composition. A complete randomized design analysis confirmed fish fed $rHGH_{10}$, $rHGH_{20}$, $rHGH_{40}$, rBST $A_{10}$, rBST $A_{20}$, rBST $A_{40}$, rBST $B_{20}$ and rBST $B_{40}$ diets for 6 weeks showed higher WG than fish fed the control diet (P<0.05). A higher FE was observed in fish fed $rHGH_{10}$, $rHGH_{20}$, $rHGH_{40}$, rBST $A_{20}$ and rBST $A_{40}$ diets in comparison to fish fed the control diet. Fish fed all graded rHGH, rBST A and rBST B supplemented diets showed a higher SGR than fish fed the control diet. Regarding PER, fish fed $rHGH_{10}$, $rHGH_{20}$, $rHGH_{40}$, rBST $A_{10}$, rBST $A_{20}$, rBST $A_{40}$ and rBST $B_{20}$ diets were higher than fish fed the control diet. Furthermore, the lysozyme activity of fish fed a diet of $rHGH_{20}$ was significantly higher than that of fish fed any other diet. The results measuring the growth and development of the fish clearly suggest the biopotency of dietary rHGH could be higher than those of both dietary rBST A and rBST B. Further implied is the probability that within the range of 10 to 40 mg/kg BW/week the dietary growth hormones could accelerate growth performance, and that 20 mg rHGH/kg BW/week could possibly enhance lysozyme activity in juvenile olive flounder, Paralichthys olivaceus.

효모에서 발현된 유전자 재조합 인간 성장호르몬의 일반 약리작용 (General Pharmacology of Recombinant Human Growth Hormone Expressed in Saccharomyces cerevisiae)

  • 이은방;신국현;정명숙;김운자;윤기영;김정근
    • 약학회지
    • /
    • 제34권6호
    • /
    • pp.439-446
    • /
    • 1990
  • The general pharmacological actions of recombinant human growth hormone (rHGH) were investigated. It had hypothermic action but neither sedative nor analgesic action. No pharmacological effects were observed in isolated guinea pig ileum and tracheal muscle and rat fundus and uterus. Slight hypotensive action with no effect on respiration was revealed at a dose of 20 IU/kg i.v. of rHGH in rabbits. The rHGH exhibited a weak inhibitory action of glucose tolerance in normal rats, significantly lowered the blood glucose contents in adrenalectomized rats 20 min after i.v. administration (80IU/kg), and produced a significant inhibitory effect on in vitro glycerol release in epinephrine-stimulated epididymal fat pad segments of rats.

  • PDF